Sara Colombetti

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

Roberta Palumbo, Maurilio Sampaolesi, Francesco De Marchis et al. · The Journal of Cell Biology · 2004 · 463 citations · Full text

Immunology, Cell Death, Cell Proliferation +19

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 361 citations

Dc Gene Signature, Tumor Immunology, Cancer Immunosurveillance +11

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 342 citations · Full text

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 252 citations · Full text

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 238 citations · Full text